Reference health

The Value of the Corporate Governance Canon on Chinese Companies

https://doi.org/10.2139/ssrn.3101277
CiteStamped reference-health badge
34/34 checkable references clean · checked 2026-08-27

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

37 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 34 checked references that resolve
resolves10.1007/s10551-014-2387-1
Good Apples, Bad Apples: Sorting Among Chinese Companies Traded in the U.S.
resolves10.1016/j.jce.2004.07.002
Corporate governance and market valuation in China
resolves10.1016/j.jcorpfin.2008.03.005
Adopting better corporate governance: Evidence from cross-border mergers
resolves10.1111/j.1468-036x.2012.00648.x
The Impact of the Corporate Governance Code on Earnings Management – Evidence from Chinese Listed Companies
resolves10.1016/j.chieco.2008.01.002
Does corporate governance matter in China?
resolves10.1016/j.jaccpubpol.2010.02.001
A transparency Disclosure Index measuring disclosures: Chinese listed companies
resolves10.1111/j.1468-036x.2008.00446.x
Corporate Governance in China: a Step Forward
resolves10.1111/j.1467-646x.2007.01009.x
Do Investors Really Value Corporate Governance? Evidence from the Hong Kong Market
resolves10.1093/wbro/lkj004
Corporate Governance and Development
resolves10.2139/ssrn.2545685
The Spillover Effect of Fraud Allegations Against Chinese Reverse Mergers
resolves10.1057/jdg.2009.16
Local versus global: Corporate governance practices in Chinese domestic and overseas companies
resolves10.1016/j.jacceco.2006.07.002
The Sarbanes–Oxley Act and firms’ going-private decisions
resolves10.1108/18325910910986981
Board of directors' governance challenges and earnings management
resolves10.1016/j.jcorpfin.2010.09.002
Cooking the books: Recipes and costs of falsified financial statements in China
resolves10.22495/cocv11i3conf2p4
Corporate governance standards in cross-border investing: lessons learned from Chinese companies listed in the United States
resolves10.1007/s11156-012-0313-0
Corporate governance and market segmentation: evidence from the price difference between Chinese A and H shares
resolves10.1016/j.chieco.2014.02.003
The impact of local governance institutions on foreign market listings: The case of Chinese firms
resolves10.2139/ssrn.956020
An Examination of the Impact of the Sarbanes-Oxley Act on the Attractiveness of US Capital Markets for Foreign Firms
resolves10.1016/j.jacceco.2013.05.001
Individual investors and financial disclosure
resolves10.2308/accr-50960
Shell Games: The Long-Term Performance of Chinese Reverse-Merger Firms
resolves10.2139/ssrn.1726592
Ownership Structure, Corporate Governance and Firm Value: Evidence from Chinese Listed Companies
resolves10.1016/j.jcorpfin.2014.10.008
Cross-listing, firm-specific information, and corporate governance: Evidence from Chinese A-shares and H-shares
resolves10.1002/mde.1463
Corporate governance and firm efficiency: evidence from China's publicly listed firms
resolves10.2139/ssrn.1120971
Defensive Management: Does the Sarbanes-Oxley Act Discourage Corporate Risk-Taking?
resolves10.1016/j.jcorpfin.2009.11.002
Can corporate governance deter management from manipulating earnings? Evidence from related-party sales transactions in China
resolves10.1787/9789264241725-en
Corporate Governance of Company Groups in Latin America
resolves10.1016/j.rdf.2012.05.002
ADR characteristics and corporate governance in the Greater China region
resolves10.1111/j.1475-679x.2008.00279.x
Regulation and Bonding: The Sarbanes‐Oxley Act and the Flow of International Listings
resolves10.1080/13602380903522325
Corporate governance mechanisms and financial performance in China: panel data evidence on listed non financial companies
resolves10.2307/3100104
Extraterritoriality and the Corporate Governance Law
resolves10.1016/s0378-4266(03)00119-5
Location of trade, ownership restrictions, and market illiquidity: Examining Chinese A- and H-shares
resolves10.1016/j.jcorpfin.2007.03.001
Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value
resolves10.1111/1540-6288.00029
Information Flows across Markets: Evidence from China–Backed Stocks Dual–Listed in Hong Kong and New York
resolves10.1111/j.1467-8683.2009.00754.x
Non‐Tradable Share Reform and Corporate Governance in the Chinese Stock Market
The 37 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref4
no DOI — not checkedOur purpose does not consist in trying every out about these data... only to show that corporate governance matters. For readers interested in figuring out that informational and other factors play a small role in these shares' price movements relative to corporate governance should dated, but still relevant
no DOI — not checkedref6
no DOI — not checkedref7
no DOI — not checkedref9
no DOI — not checkedref15
no DOI — not checkedSocial Disclosure
no DOI — not checkedref18
no DOI — not checkedref19
no DOI — not checkedCorporate Governance Reform: How to Promote the Long-Term Health and Value of U.S. Corporations
no DOI — not checkedref23
no DOI — not checkedref26
no DOI — not checkedref28
no DOI — not checkedCorporate Governance and Firm Value: The Impact of the 2002 Governance Rules
no DOI — not checkedScrutiny Greets Overseas-Listed Chinese Companies Returning Home to Relist
no DOI — not checkedref33
no DOI — not checkedref34
no DOI — not checkedref35
no DOI — not checkedSarbanes-Oxley Act, Related Legal Issues, and Global Comparisons
no DOI — not checkedref37
no DOI — not checkedref40
no DOI — not checkedref41
no DOI — not checkedref42
no DOI — not checkedref45
no DOI — not checkedref49
no DOI — not checkedFinancial Transparency and Disclosure: China Progess on Corporate Governance
no DOI — not checkedref55
no DOI — not checkedref58
no DOI — not checkedThe Long-term Valuation Impact of Sarbanes-Oxley on U.S. vs. Foreign Firms
no DOI — not checkedref63
no DOI — not checkedref64
no DOI — not checkedMandatory Financial Reporting and Voluntary Disclosure: The Effect of Mandatory IFRS Adoption on Management Forecasts
no DOI — not checkedref68
no DOI — not checkedref69
no DOI — not checkedref70
no DOI — not checkedCross Listing, Corporate Governance and Corporate Performance: Empirical Evidence of Hong Kong-Listed Chinese Companies
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-27 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3101277"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3101277/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3101277/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3101277)